CLINICAL_TRIALS
trial_result
· 2021-01-15
Clinical Trial Update: Study to Evaluate the Pharmacokinetics of Filgotinib in Participants With Impaired Hepatic Function [Phase 1]
Summary
Phase 1 pharmacokinetics study of filgotinib in participants with impaired hepatic function completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gilead Sciences | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED | Results posted: 2021-01-15